News
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
18h
Khaleej Times on MSNUAE retail investors charged into EV, tech, and telehealth stocks in Q2 2025According to data from eToro, leading the list was telehealth platform, Hims & Hers Health, which surged 85 per cent in ...
Half of folks who say they always feel lonely (50%) have clinical depression, compared with just 10% of those who report ...
The medication finasteride has become popular among young men. But for those struggling to conceive, it could be the reason.
20h
Zacks Investment Research on MSNReasons to Add Fresenius Medical Stock to Your Portfolio NowFresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a solid global foothold. However, a tough regulatory environment remains a ...
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
The U.S. stock market enters Q2 earnings season in a precarious position. The S&P 500’s nearly 28% rebound from April lows has pushed valuations to elevated levels, with the forward price-to-earnings ...
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful conclusion of negotiations with the pan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results